What’s In This Issue HPV Vaccination: How Can We Do Better?

Volume 16 ? Number 4

October 2012

(Content current

VACCINATE ADULTS!asofOctober16)

from the Immunization Action Coalition --

What's In This Issue

HPV Vaccination: How Can We Do Better?....... 1

Ask the Experts: CDC answers questions.......... 1

Peek at the Redesign of IAC's Website for the Public, ................... 2

Vaccine Highlights: Recommendations, schedules, and more.......................................... 4

IAC Welcomes Dr. William Atkinson as Associate Director for Immunization Education............ 5

Influenza Education Materials for Patients & Staff................................................................. 6

Screening for Influenza Vaccine Contraindications................................................ 7

Standing Orders for Administering Influenza Vaccine to Adults................................. 8

Standing Orders for Administering Pneumococcal (PPSV23 and PCV13) Vaccine to Adults................................................ 9

First Do No Harm: Mandatory Influenza Vaccination Policies for Healthcare Personnel Help Protect Patients......................... 10

Influenza Vaccine Products for 2012?2013........ 12

Poster: No More Excuses: There Are Many Places to Get Your Flu Vaccine.......................... 13

New! Influenza Vaccination of People with a History of Egg Allergy......................................... 14

Poster: Protect Your Baby from Serious Diseases....16

New! Cocooning Protects Babies....................... 17

IAC's Immunization Resources Order Form....... 18

HPV Vaccination: How Can We Do Better?

Recently released data on vaccination coverage of teen girls and boys age 13?17 shows the rate of HPV vaccination lags way behind rates of Tdap and meningococcal conjugate (MCV4) vaccination. Since 2006?07, when the Centers for Disease Control and Prevention (CDC) recommended the three vaccines for use in adolescents, coverage with Tdap and MCV4 has increased steadily. But HPV coverage has plateaued. Vaccination coverage of teens in 2011 for the three vaccines follows:

? Coverage with 1 or more doses of Tdap vaccine was 78.2%.

? Coverage with 1 or more doses of MCV4 was 70.5%.

? Coverage with 1 or more doses of HPV among teenage girls was 53.0%, and coverage with 3 or more doses was 34.8%.

Cervical Cancer Prevention Annually in the United States, 12,000 new cases of cervical cancer are diagnosed and 4000 cervical cancer deaths occur. HPV vaccine, which prevents infections that cause about 70% of cervical cancers, holds the prospect of being an incredible cancer-prevention tool for an entire generation of women. Tragically, that prospect is not now being fully realized--but healthcare professionals have the opportunity to turn the tide.

An article in the September 2012 issue of AAP News states that a "pediatrician's strong recommendation is the key to helping parents with their decision" to vaccinate their child with HPV vaccine and that "if a dose of HPV vaccine were

administered each time a clinician gave Tdap or MCV4, coverage could jump to more than 80%."

In a recent letter addressed to CDC grantees and partners, Dr. Anne Schuchat, director, CDC's National Center for Immunization and Respiratory Diseases, outlines a call to action that involves promoting HPV vaccination to physician audiences, immunization providers, and parents of preteen and teen girls and boys. To that end, CDC has developed several new HPV resources, as have other respected partner organizations. A selection of them follows.

HPV Resources ? CDC's HPV web section: hpv

? 19-minute Medscape video, "HPV Vaccine: A Shot of Cancer Prevention," Anne Schuchat, MD; Lauri E. Markowitz, MD; Mona Saraiya, MD, MPH. Released: 08/10/2012; valid for credit through 08/10/2013: viewarticle/768633

? CDC parent education sheet: vaccines/vpd-vac/hpv/downloads/dis-HPVcolor-office.pdf

? IAC's HPV web section: resources/dis_hpv.asp

? IAC's HPV video collection: immunize. org/votw/hpv-videos.asp

? Four videos for parents on Children's Hospital of Philadelphia's HPV web section: chop. edu/service/vaccine-education-center/preventhpv/index.html

? Heather's story: user/ immunizationaction

Ask the Experts

IAC extends thanks to our experts, medical epidemiologist Andrew T. Kroger, MD, MPH; nurse educator Donna L. Weaver, RN, MN; and medical officer Iyabode Akinsanya-Beysolow, MD, MPH. All are with the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC).

Immunization questions?

? Call the CDC-INFO Contact Center at (800) 232-4636 or (800) CDC-INFO

? Email nipinfo@ ? Call your state health dept. (phone numbers

at coordinators)

Influenza vaccine

What is the latest CDC guidance on influenza vaccination and egg allergy? People who have experienced a serious systemic or anaphylactic reaction (e.g., hives, swelling of the lips or tongue, acute respiratory distress, or collapse) after eating eggs should consult a specialist for appropriate evaluation to help determine if vaccine should be administered.

A previous severe allergic reaction to influenza vaccine, regardless of the component suspected to be responsible for the reaction, is a contraindication to future receipt of the vaccine.

People who have documented immunoglobulin E (IgE)-mediated hypersensitivity to eggs, including those who have had occupational asthma or other allergic responses to egg protein, might also be at increased risk for allergic reactions to influenza vaccine. Protocols have been published for safely administering influenza vaccine to people with

(continued on page 5)

FEDERAL and MILITARY

EMPLOYEES

Make the Immunization Action Coalition

your charity of choice for the Combined Federal Campaign.

Use agency code

#10612

The Immunization Action Coalition is a 501(c)(3) charitable organization and your contribution is tax-deductible

to the fullest extent of the law.

Vaccinate Adults!

online at va

Immunization Action Coalition

1573 Selby Avenue, Suite 234 St. Paul, MN 55104

Phone: (651) 647-9009 Fax: (651) 647-9131 Email: admin@ Websites:

Vaccinate Adults is a publication of the Immunization Action Coalition (IAC) written for health professionals. Content is reviewed by the Centers for Disease Control and Prevention (CDC) for technical accuracy. This publication is supported by CDC Grant No. U38IP000589. The content is solely the responsibility of IAC and does not necessarily represent the official views of CDC. ISSN 1526-1824.

Publication Staff Editor: Deborah L. Wexler, MD Associate Editor: Diane C. Peterson Managing Editor: Dale Thompson, MA Edit./Opr. Asst.: Janelle T. Anderson, MA Consultants: Teresa A. Anderson, DDS, MPH Linda A. Moyer, RN, and Mary Quirk

Layout: Kathy Cohen Website Design: Sarah Joy

IAC Staff Assoc. Director for Immunization Education:

William L. Atkinson, MD, MPH Associate Director for Research: Sharon G. Humiston, MD, MPH Coordinator for Public Health:

Laurel Wood, MPA Asst. to the Director: Julie Murphy, MA

Operations Manager: Robin VanOss Associate Operations Manager: Casey Pauly

IAC publishes a free email news service (IAC Express) and two free periodicals (Needle Tips and Vaccinate Adults). To subscribe to any or all of them, go to subscribe.

IAC, a 501(c)(3) charitable organization, publishes practical immunization information for health professionals to help increase immunization rates and prevent disease.

The Immunization Action Coalition is also supported by

Merck Sharp & Dohme Corp. GlaxoSmithKline ? Novartis Vaccines

sanofi pasteur ? Pfizer Inc. MedImmune, Inc. ? CSL Biotherapies

Ortho Clinical Diagnostics, Inc. American Pharmacists Association Mark and Muriel Wexler Foundation

Anonymous Many other generous donors

IAC maintains strict editorial independence in its publications.

IAC Board of Directors

Stephanie L. Jakim, MD Olmsted Medical Center

James P. McCord, MD Children's Hospital at Legacy Emanuel

Sheila M. Specker, MD University of Minnesota

Debra A. Strodthoff, MD Amery Regional Medical Center

Deborah L. Wexler, MD Immunization Action Coalition

Peek at the Redesign of IAC's Website for the Public, !

Before the end of 2012, the Immunization Action Coalition (IAC) will be launching a major redesign of its website for the public, . Offering information about vaccination for the entire lifespan, the newly designed website will be organized by age group--Infants & Children, Preteens, Teens, and Adults. It will offer your patients accurate information and valuable resources from trusted organizations.

SNEAK PEEK AT THE CONTENT

? Resources Frequently updated listing of helpful resources for people in all age groups who seek information about vaccines

? Vaccine-Preventable Diseases Information and resources for all vaccine-preventable diseases, including those associated with international travel

? Schedules Detailed information about the immunization schedules broken down by age group-- infants and children, preteens, teens, and adults

? Personal Testimonies Stories of suffering and loss from vaccine-preventable diseases

? Videos

Collection of hundreds of videos and public service announcements about vaccine-preventable diseases and the importance of vaccination

? The Basics

Basic and helpful information on vaccines, ranging from "How to Pay for Vaccines" to "How Vaccines Work"

IAC will announce the launch of the redesigned , in IAC Express, our free weekly email news service. If you would like to start receiving weekly email announcements about important developments related to immunization, as well as the future notification of the redesign launch, we urge you to complete the sign-up form at subscribe.

DISCLAIMER: Vaccinate Adults! is available to all readers free of charge. Some of the information in this issue is supplied to us by the Centers for Disease Control and Prevention in Atlanta, Georgia, and some information is supplied by third-party sources. The Immunization Action Coalition (IAC) has used its best efforts to accurately publish all of this information, but IAC cannot guarantee that the original information as supplied by others is correct or complete, or that it has been accurately published. Some of the information in this issue is created or compiled by IAC. All of the information in this issue is of a time-critical nature, and we cannot guarantee that some of the information is not now outdated, inaccurate, or incomplete. IAC cannot guarantee that reliance on the information in this issue will cause no injury. Before you rely on the information in this issue, you should first independently verify its current accuracy and completeness. IAC is not licensed to practice medicine or pharmacology, and the providing of the information in this issue does not constitute such practice. Any claim against IAC must be submitted to binding arbitration under the auspices of the American Arbitration Association in St. Paul, Minnesota.

2 Vaccinate Adults! ? October 2012 ? Immunization Action Coalition ? (651) 647-9009 ? ?

Wallet-sized immunization record cards for all ages: For adults, children & teens, and for a lifetime!

Now you can give any patient a permanent vaccination record card designed specifically for their age group: adult, child & teen, or lifetime. These brightly colored cards are printed on durable rip-, smudge-, and water-proof paper. To view the cards or for more details, go to shop and click on the images. Buy 1 box (250 cards) for $45 (first order of a 250-card box comes with a 30-day, money-back guarantee). Discounts for larger orders: 2 boxes $40 each; 3 boxes $37.50 each; 4 boxes $34.50 each

To order, visit shop, or use the order form on page 18. To receive sample cards, contact us: admininfo@

"Immunization Techniques -- Best Practices with Infants, Children, and Adults"

The California Department of Public Health, Immunization Branch, updated its award-winning training video, "Immunization Techniques: Best Practices with Infants, Children, and Adults." The 25-minute DVD can be used to train new employees and to refresh the skills of experienced staff on administering injectable, oral, and nasal-spray vaccines to children, teens, and adults. Make sure your healthcare setting has the 2010 edition!

The cost is $17 each for 1?9 copies; $10.25 each for 10?24 copies; $7 each for 25?49 copies; $5.75 each for 50?99 copies.

To order, visit shop, or use the order form on page 18. For 100 or more copies, contact us for discount pricing: admininfo@ For healthcare settings in California, contact your local health department immunization program for a free copy.

2012! Laminated adult and child immunization schedules Order one of each for every exam room

Here are the ACIP/AAFP/ACP/ACOG/ACNM-approved schedule for adults and the ACIP/AAP/AAFP-approved immunization schedule for people ages 0 through18 years. Both are laminated and washable for heavy-duty use, complete with essential footnotes, and printed in color for easy reading. The cost is $7.50 for each schedule and only $5.50 each for five or more copies.

To order, visit shop, or use the order form on page 18. For 20 or more copies, contact us for discount pricing: admininfo@

Advisory Board

Liaisons from Organizations

Bernadette A. Albanese, MD, MPH Council of State & Territorial Epidemiologists

Stephen L. Cochi, MD, MPH Nat'l Ctr. for Immun. & Resp. Diseases, CDC

Paul Etkind, DrPH, MPH Nat'l. Assn. of County & City Health Officials

Stanley A. Gall, MD Amer. College of Obstetricians & Gynecologists

Bruce Gellin, MD, MPH National Vaccine Program Office, DHHS

Neal A. Halsey, MD Institute for Vaccine Safety, Johns Hopkins Univ.

Claire Hannan, MPH Association of Immunization Managers Carol E. Hayes, CNM, MN, MPH American College of Nurse-Midwives Gregory James, DO, MPH, FACOFP

American Osteopathic Association Samuel L. Katz, MD

Pediatric Infectious Diseases Society Elyse Olshen Kharbanda, MD, MPH Society for Adolescent Health and Medicine Marie-Michele Leger, MPH, PA-C American Academy of Physician Assistants

Harold S. Margolis, MD Nat'l Ctr. for Emerg. & Zoonotic Inf. Diseases, CDC

Martin G. Myers, MD National Network for Immunization Information

Kathleen M. Neuzil, MD, MPH American College of Physicians Paul A. Offit, MD

Vaccine Education Ctr., Children's Hosp. of Phila.

Walter A. Orenstein, MD Emory Vaccine Center, Emory University

Mitchel C. Rothholz, RPh, MBA American Pharmacists Association

Thomas N. Saari, MD American Academy of Pediatrics

William Schaffner, MD Infectious Diseases Society of America

Anne Schuchat, MD Nat'l Ctr. for Immun. & Resp. Diseases, CDC

Thomas E. Stenvig, RN, PhD American Nurses Association

Kathryn L. Talkington, MPAff Assn. of State & Territorial Health Officials

Litjen Tan, PhD American Medical Association Ann S. Taub, MA, CPNP National Assn. of Pediatric Nurse Practitioners

John W. Ward, MD Division of Viral Hepatitis, NCHHSTP, CDC Patricia N. Whitley-Williams, MD, MPH

National Medical Association Walter W. Williams, MD, MPH Nat'l Ctr. for Immun. & Resp. Diseases, CDC

Individuals Hie-Won L. Hann, MD

Jefferson Medical College, Philadelphia, PA Mark A. Kane, MD, MPH Consultant, Seattle, WA

Edgar K. Marcuse, MD, MPH University of Washington School of Medicine

Brian J. McMahon, MD Alaska Native Medical Center, Anchorage, AK

Stanley A. Plotkin, MD

Gregory A. Poland, MD Mayo Clinic, Rochester, MN Sarah Jane Schwarzenberg, MD

University of Minnesota Coleman I. Smith, MD Minnesota Gastroenterology, Minneapolis, MN Richard K. Zimmerman, MD, MPH University of Pittsburgh

Vaccinate Adults! ? October 2012 ? Immunization Action Coalition ? (651) 647-9009 ? ? 3

Vaccine Highlights

Recommendations, schedules, and more

Editor's note: The information in Vaccine Highlights is current as of October 16, 2012.

The next ACIP meetings

A committee of 15 national experts, the Advisory Committee on Immunization Practices (ACIP) advises CDC on the appropriate use of vaccines. ACIP meets three times a year in Atlanta; meetings are open to the public. The next two meetings will be held on Oct. 24?25, 2012, and Feb. 20?21, 2013. For more information, visit vaccines/acip/index.html.

ACIP periodically issues recommendations on the use of vaccines. Clinicians who vaccinate should have a current set for reference. Published in the Morbidity and Mortality Weekly Report (MMWR), ACIP recommendations are easily available. Here are sources: ? Download them from links on IAC's website:

acip. ? Download them from CDC's website: cdc.

gov/vaccines/pubs/acip-list.htm.

Influenza vaccine news

On August 17, CDC published ACIP's 2012 influenza recommendations, "Prevention and Control of Influenza with Vaccines--United States, 2012?13 Influenza Season." The recommendations discuss the vaccination schedule for children age 6 months through 8 years; febrile seizures associated with administration of influenza and 13-valent pneumococcal conjugate (PCV-13) vaccines; and vaccination recommendations for people with a history of egg allergy. For a copy, see pages 613?618 of mmwr/pdf/wk/mm6132.pdf.

On August 3, CDC's Health Alert Network (HAN) issued an official CDC Health Advisory titled "Increase in Influenza A H3N2v Virus Infections in Three U.S. States." The HAN document reports between July 12 and August 3, 2012, 16 cases of H3N2v were reported and confirmed by CDC. Each of the 16 cases involved contact with swine prior to illness onset. The advisory includes interim recommendations for the public and healthcare providers, and access to resources. To access the HAN document, go to bt.cdc. gov/HAN/han00325.asp.

Pneumococcal vaccine news

On Oct. 12, CDC published ACIP recommendations titled "Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions." The recommendations follow:

Adults with the conditions specified below who are eligible for pneumococcal vaccine should be vaccinated with 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13; Pfizer) during their next pneumococcal vaccination opportunity.

For pneumococcal vaccine-na?ve people ACIP recommends that adults age 19 years and older with immunocompromising conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants, who have not previously received PCV13 or 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23; Merck), receive a dose of PCV13 first, followed by a dose of PPSV23 at least 8 weeks later. Subsequent doses of PPSV23 should follow current PPSV23 recommendations for adults at high risk. Specifically, a second PPSV23 dose is recommended 5 years after the first PPSV23 dose for adults age 19 through 64 years with functional or anatomic asplenia and for people with immunocompromising conditions. Additionally, those who received PPSV23 before age 65 years for any indication should receive another dose of the vaccine at age 65 years, or later if at least 5 years have elapsed since their previous PPSV23 dose.

For people previously vaccinated with PPSV23 Adults age 19 years and older with immunocompromising conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants, who previously have received 1 or more doses of PPSV23 should be given a PCV13 dose 1 or more years after the last PPSV23 dose was received. For those who require additional doses of PPSV23, the first such dose should be given no sooner than 8 weeks after PCV13 and at least 5 years after the most recent dose of PPSV23.

To access the CDC recommendations, see pages 816?819 of MMWR at mmwr/pdf/ wk/mm6140.pdf. Or for the web text version, go to mmwr/preview/mmwrhtml/ mm6140a4.htm.

Vaccine coverage 2011?2012

On Aug. 31, CDC published "National and State Vaccination Coverage Among Adolescents Aged 13?17 Years--United States, 2011." The National Immunization Survey-Teen (NIS-Teen) provides vaccination coverage estimates for teens age 13?17 years in the 50 states, District of Columbia, seven selected local areas, and U.S. Virgin Islands. Access NIS-Teen on pages 671?677 of mmwr/pdf/wk/mm6134.pdf or go to mmwr/preview/mmwrhtml/mm6134a3.htm.

Subscribe to IAC Express!

subscribe

Get weekly updates

on vaccine information

while it's still news!

All the news we publish in "Vaccine Highlights" will be

sent by email to you every Tuesday. Free!

To sign up, visit

subscribe

At the same time, you'll be able to sign up to receive other free IAC publications!

New and updated VISs

The use of most Vaccine Information Statements (VISs) is mandated by federal law. Listed below are the dates of the most current VISs. Check your stock of VISs against this list. If you have outdated VISs, print current ones from IAC's website at immunize. org/vis. You'll find VISs in more than 30 languages. DTaP/DT/DTP..... 5/17/07 MMRV...............5/21/10 Hepatitis A...... 10/25/11 PCV13................4/16/10 Hepatitis B ......... 2/2/12 PPSV ................ 10/6/09 Hib ................. 12/16/98 Polio ................. 11/8/11 HPV (Cervarix)...... 5/3/11 Rabies .............. 10/6/09 HPV (Gardasil).....2/22/12 Rotavirus........... 12/6/10 Influenza (LAIV)......7/2/12 Shingles............ 10/6/09 Influenza (TIV).......7/2/12 Td/Tdap ............ 1/24/12 Japan. enceph...12/7/11 Typhoid............. 5/29/12 Meningococcal..10/14/11 Varicella ........... 3/13/08 MMR.................4/20/12 Yellow fever ..... 3/30/11

Multi-vaccine VIS.......9/18/08

(for 6 vaccines given to infants/children: DTaP, IPV, Hib, HepB, PCV, RV)

For a ready-to-print version of this table for posting in your practice, go to catg.d/ p2029.pdf.

4 Vaccinate Adults! ? October 2012 ? Immunization Action Coalition ? (651) 647-9009 ? ?

Ask the Experts . . . continued from page 1

egg allergies. Some people who report allergy to egg might not

be egg allergic. If a person can eat lightly cooked eggs (e.g., scrambled eggs), they are unlikely to have an egg allergy. However, people who can tolerate egg in baked products (e.g., cake) might still have an egg allergy. If the person develops hives only after ingesting eggs, CDC recommends (1) they receive TIV (not LAIV), (2) the vaccine be administered by a healthcare provider familiar with the potential manifestations of egg allergy, and (3) the vaccine recipient be observed for at least 30 minutes after receipt of the vaccine for signs of a reaction.

For more details about giving influenza vaccine to people with a history of egg allergy, see "Influenza Vaccination of People with a History of Egg Allergy" on page 14 of this issue of Vaccinate Adults or visit catg.d/p3094. pdf. You can also consult pages 616?617 of "Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP--U.S., 2012?13 Influenza Season" at mmwr/pdf/wk/ mm6132.pdf.

Which formulations of influenza vaccines (i.e., nasal spray, intradermal, injectable high-dose, and injectable standard-dose) are recommended for various age groups? Six manufacturers are producing influenza vaccines for the U.S. market for the 2012?13 season. Page 12 of this issue of Vaccinate Adults has a table titled "Influenza Vaccine Products for the 2012?2013 Influenza Season." It summarizes the vaccine products and age groups for which they are licensed.

In recommending influenza vaccination for people age 65 and older, does CDC prefer that healthcare professionals administer high-dose influenza vaccine or standard-dose influenza vaccine? CDC has no preference. CDC stresses that vaccination is the first and most important step in protecting against influenza.

If a patient received a dose of influenza vaccine in June (e.g., for international travel), how long should the patient wait before getting vaccinated with the next season's flu vaccine? There should be a minimum of 4 weeks between the doses in such situations.

Other vaccines

Can adolescents and adults who have been exposed to pertussis be vaccinated if they

Vaccinate Adults correction policy

If you find an error, please notify us immediately by sending an email message to admin@. We publish notification of significant errors in our email announcement service, IAC Express. Be sure you're signed up for this service. To subscribe, visit subscribe.

haven't had a one-time dose of Tdap yet? Yes. Exposure to a person with pertussis is not a reason to avoid Tdap vaccination. All adolescents and adults who haven't had a one-time dose of Tdap should receive a dose as soon as possible.

Should a person who received 2 doses of varicella vaccine be vaccinated with zoster vaccine when they turn 60? No. CDC does not currently recommend zoster vaccine for people who received 2 doses of varicella vaccine. However, healthcare providers do not need to inquire about varicella vaccination history before administering zoster vaccine because virtually all people currently or soon to be in the recommended age group have not received varicella vaccine. For details, see page 19 of the CDC recommendations Prevention of Herpes Zoster available at mmwr/PDF/rr/ rr5705.pdf.

Can we accept receipt of a single documented dose of zoster vaccine as proof of varicella immunity in a healthcare employee who has no other evidence of immunity? No. Receipt of zoster vaccine is not proof of prior varicella disease. According to CDC, acceptable evidence of varicella immunity in healthcare

personnel includes (1) documentation of 2 doses of varicella vaccine given at least 28 days apart, (2) history of varicella or herpes zoster based on physician diagnosis, (3) laboratory evidence of immunity, or (4) laboratory confirmation of disease. If a healthcare employee has already received a dose of zoster vaccine but has no evidence of immunity to varicella, the zoster dose can be considered the first dose of the 2-dose varicella series.

I work in employee health. Several hospital employees have told me they have had

(continued on page 15)

Stay current with FREE subscriptions

The Immunization Action Coalition's 2 periodicals, Vaccinate Adults and

Needle Tips, and our email news service, IAC Express, are packed

with up-to-date information.

Subscribe to all 3 free publications in one place. It's simple! Go to

subscribe

IAC Welcomes Dr. William Atkinson as Associate Director for Immunization Education

William L. Atkinson, MD,

MPH, recently joined the

Immunization Action Co-

alition as associate director

for immunization educa-

tion. In July, Dr. Atkinson

retired from the Centers for

Disease Control and Preven-

William L. Atkinson, MD, MPH

tion (CDC) after 25 years of

service. At the time of his retirement, he was

medical epidemiologist and training team lead,

Immunization Services Division, National Cen-

ter for Immunization and Respiratory Diseases

(NCIRD), a position he held for 17 years. In

that role, he pioneered the use of satellite and

broadcast technology to bring immunization ed-

ucation to thousands of immunization providers

simultaneously. During his tenure at CDC, he

produced, wrote, and/or appeared in more than

100 broadcasts and webcasts that were viewed

by more than 300,000 healthcare providers. He

also gave more than 600 invited lectures and

taught more than 100 two-day training courses

across the United States, addressing more than

150,000 attendees.

Dr. Atkinson's skill as a communicator is not limited to his speaking prowess. He excels as a writer, as well. In 1995, he conceived, developed, and took the lead in writing one of CDC's most widely sought-after books, Epidemiology and

Prevention of Vaccine-Preventable Diseases (aka the Pink Book). The book is now in its twelfth edition, and more than 400,000 copies have been distributed. He is the author or coauthor of 52 publications and book chapters primarily relating to measles and other vaccine-preventable diseases. He contributed to several editions of the American Academy of Pediatrics Red Book and to Vaccines, the highly regarded textbook edited by Stanley A. Plotkin, MD, Walter A. Orenstein, MD, and Paul A. Offit, MD.

Since 1989, he has been a member of multiple work groups for the Advisory Committee on Immunization Practices (ACIP), and is currently a member of work groups responsible for developing CDC's harmonized child and adolescent immunization schedule, general immunization recommendations, meningococcal recommendations, and pertussis recommendations.

Dr. Atkinson was the first recipient of CDC's highest immunization honor, the Phil Horne Award. He was also the 2001 recipient of the Bill Watson Medal of Excellence, the highest award given to a CDC employee, and the 2003 Excellence in Distance Training Award of the United States Distance Learning Association. He was a recipient of the IAC Superhero Award in 2001.

Dr. Atkinson's photograph has been added to IAC's staff web page at aboutus/iacstaff.asp.

Vaccinate Adults! ? October 2012 ? Immunization Action Coalition ? (651) 647-9009 ? ? 5

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download